Effect of cyproheptadine on episodic ACTH and cortisol secretion

European Journal of Clinical Investigation

Volumn 26, Issue 5, 1996, Pages 397-403

  Schurmeyer T H ^a   Brademann, G ^a   Von Zur Muhlen A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ACTH; circadian rhythm; cortisol; cyproheptadine; episodic hormone secretion

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYPROHEPTADINE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DRUG EFFECT; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM;

EID: 0029982678     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.143305.x     Document Type: Article

References (60)

1. Krieger DT. Rhythm of ACTH and corticosteroid secretion in health and disease, and their experimental modification. J Steroid Biochem 1975;6:785-91.
2. Szafarczyk A, Alonso G, Ixart G, Malaval F, Nouguier-Soule J, Assenmacher I. Serotonergic system and circadian rhythms of ACTH and corticosterone in rats. Am J Physiol 1980;239:482-9.
3. Lengvári I, Szelier M. Independence of diurnal rhythms of plasma corticosterone and hypothalamic serotonin content. Endocrinology 1980;76:297-302.
4. Scapagnini U, Moberg GP, Van Loon GR, deGroot J, Ganong WF. Relation of brain 5-hydroxytryptamine content to the diurnal variation in plasma corticosterone in the rat. Neuroendocrinology 1971;7:90-6.
5. Chihara K, Kato Y, Maeda K, Matsukura S, Imura H. Suppression by cyproheptadine on human growth hormone and cortisol secretion during sleep. J Clin Invest 1976;57:1393-402.
6. Delitala G, Masala A, Alagna S, Devilla L. Effect of cyproheptadine on spontaneous diurnal variation of ACTH and ACTH-GH response to L-dopa in man. Biomedicine 1975;23:406-409.
7. Jones MT, Birmingham N, Gillham B, Holmes M, Smith T. The effect of cyproheptadine on the release of corticotrophin releasing factor. Clin Endocrinol 1979;10:203-5.
8. Krieger DT, Rizzo F. Serotonin mediation of circadian periodicity of plasma 17-hydroxycorticosteroids. J Physiol 1969; 1703-7.
9. Loli P, Frascatani F, Gelli D, Maggioni M, Muratori F, Ronzoni M. Inhibitory effect of cyproheptadine on ACTH secretion in patients with Addison's disease. Acta Endocrinol 1983;102:111-15.
10. Plonk J, Feldman JM. Modification of adrenal function by the antiserotonin agent cyproheptadine. J Clin Endocrinol Metab 1976;42:291-5.
11. Allolio B, Schulte HM, Winkelmann W. Cyproheptadine inhibits the corticotropin releasing hormone (CRH)-induced hormone release in normal subjects. Horm Metab Res 1987; Suppl.16: 36-8.
12. Hirata Y, Nakashima H, Uchihashi M, Tomita M, Fujita T, Ikeda M. Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome. Endocrinol Japon 1984;31:619-26.
13. Ishibashi M, Yamaji T. Direct effects of thyrotropin-releasing hormone, cyproheptadine and dopamine on a adrenocorticotropin secretion from human corticotroph adenoma cells in vitro. J Clin Invest 1981;68:1018-27.
14. Lamberts SWJ, Verleun T, Bons EG, Uitterlinden P, Oosterom R. 1983 Effect of cyproheptadine, desmethylcyproheptadine. γ-aminobutyric acid and sodium valproate on adrenocorticotrophin secretion by cultured pituitary tumor cells from three patients with Nelson's syndrome. J Endocrinol 1983;96:401-6.
15. Suda T, Tozawa F, Mouri T, Sasaki A, Shibasaki T, Demura H, Shizume K. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease. J Clin Endocrinol Metab 1983;56:1094-9.
16. Krause U, Nink M, Brauer A et al. Studies on facial temperature rise and involvement of serotonin in the respiratory stimulation by CRH. Horm Metab Res 1991;23:499-503.
17. Buckingham JC, Hodges JR. Hypothalamic receptors involved in the secretion of corticotrophin releasing factor. J Physiol 1979;290:421-31.
18. George WF, Husain M, Lock JP, Katz FH. Failure of cyproheptadine to inhibit vasopressin-stimulated cortisol release in a patient with Cushing's disease. Horm Res 1976;7:308-12.
19. Lankford HV, Tucker HS, Blackard WG. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease. N Engl J Med 1981;305:1244-8.
20. Nakagami Y, Suda T, Yajima F et al. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro. Brain Res 1986;386:232-6.
21. Spinedi E, Gaillard RC. Stimulation of the hypothalamo pituitary adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin. J Endocrinol Invest 1991;14:551-7.
22. Nicholson WE, Davis DR, Sherrell BJ, Orth DN. Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem 1984;30:259-65.
23. Veldhuis JD, Johnson ML. Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol 1986; 13: E486-E493.
24. Merriam GR, Wachter KW. Algorithms for the study of episodic hormone secretion. Am J Physiol 1982; 243: E310-E318.
25. Ranft U, Prank K, Brabant G. Detection of episodic secretion activity by discrete deconvolution (DESADE) a new method for the analysis of episodic hormone secretion. Acta Endocrinol 1988; 177 (Suppl. 287): 79-80.
26. Oerter KE, Guardabasso V, Rodbard D. Detection and characterization of peaks and estimation of instantaneous secretory rates for episodic pulsatile hormone secretion. Comp Biomed Res 1986;19:170-91.
27. Tagliamonte A, Biggio G, Targiu L, Gessa GL. Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. Life Sci 1973;12:277-87.
28. Duhault J, Beregi L Roman R. Substituted phenethylamines and anorexia. Prog Neuropsychopharmacol Biol Psychiatr 1980;4:341-9.
29. Jouvet M. Biogenic amines and the states of sleep. Science 1969;163:32-41.
30. Roberts MHT. Hydroxytryptamine and antinociception. Neuropharmacology 1984;23:1529-36.
31. Van Praag HM. Brain serotonin, mood-regulation and agression-regulation. In: Pichot P, Brenner P, Wolf R, Thau K, eds. Psychiatry, the State of the Art, Vol. 2. New York: Plenum Press, 1985; 327-39.
32. Bradley PB, Engel G, Feniuk W et al. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986;25:563-76.
33. Fuller RW. The involvement of serotonin in regulation of pituitary adrenocortical function. Front Neuroendocrinol 1992;13:250-70.
34. Gartside SE, Ellis PM, Sharp T, Cowen PJ. Selective 5-HTI A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments. Eur J Pharmacol 1992;221:27-33.
35. Stone CA, Wenger HC, Ludden CT, Stavorski JM, Ross CA. Anti-serotonin-antihistaminic properties of cyproheptadine. J Pharmacol Exp Ther 1961;131:73-84.
36. Mylecharane EJ. 5-HT2 receptor antagonists and migraine therapy. J Neurol 1991;238 (Suppl.):1P S45-52.
37. Armanini D, Goland GJ, Adam WR, Funder JW. Cyproheptadine and mineralocorticoid receptors. J Clin Endocrinol Metab 1983;56:397-400.
38. Reylon V, Farooq A. Cyprohepadine: a non-specific competitor of steroid hormone receptors. Indian J Exp Biol 1984;22:284-5.
39. Jialal I, Pillay NL. Cyproheptadine therapy in Cushing's disease and Nelson's syndrome. S Afr Med J 1980;57:305-305.
40. Kasperlik-Zaluska A, Migdalska B, Hartwig W, Wilczynska J, Stopinska-Gluszak U, Lozinska D. Two pregnancies in a woman with Cushing's syndrome treated with cyproheptadine. Br J Obstet Gynaecol 1980;87:1171-3.
41. Krieger DT, Amorosa L, Linick F. Cyproheptadine-induced remission of Cushing's Disease. N Engl J Med 1975;293:893-6.
42. Krieger DT, Luria M. Effectiveness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson's syndrome. J Clin Endocrinol Metab 1976;43:1179-82.
43. Fuller RW. Serotonergic stimulation of pituitary adrenocortical function in rats. Neuroendocrinology 1981;32:118-27.
44. Holmes MC, Di Renzo G, Beckford U, Gillham B, Jones MT. Role of serotonin in the control of secretion of corticotropin releasing factor. J Endocrinol 1982;93:151-60.
45. Naumenko EV. Effect of local injection of 5-hydroxy-tryptamine into rhinencephalic and mesencephalic structures on pituitary adrenal function in guinea pigs. Neuroendocrinology 1969;5:81-8.
46. Armario A, Marti O, Gavalda A. Negative feedback of corticosterone on the pituitary adrenal axis is maintained after inhibition of serotonin synthesis with parachlorophenylalanine. Brain Res Bull 1992;28:915-18.
47. Kletzky OA, Marrs RP, Nicoloff JT. Effects of cyproheptadine on insulin-induced hypoglycaemia secretion of PRL, GH and cortisol. Clin Endocrinol (Oxf) 1980;13:231-4.
48. Plonk JW, Bivens CH, Feldman JM. Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine. J Clin Endocrinol Metab 1974;38:836-840.
49. Racz K, Wolf I, Kiss R, Lada S, Vida S, Glaz E. Corticosteroidogenesis by isolated human adrenal cells: effect of serotonin and serotonin antagonists. Experientia 1979;35:1532-4.
50. Touitou Y, Bogdan A, Auzeby A. Cyproheptadine and adrenocortical function. J Pediatr 1979;95:155-6.
51. Lefebvre HR, Contesse V, Delarue C et al. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype. Neuroscience 1992;47:999-1007.
52. Thompson CJ, Jones IR, Walker M, Baylis PH, Kendall-Taylor P. The effects of the specific serotonin antagonist ICI 169 369 on the pituitary hormone response to insulin-induced hypoglycaemia in humans. Clin Endocrinol (Oxf) 1992;36:235-40.
53. Pijl H, Koppeschaar HP, Willekens FL, Frolich M, Meinders AE. The influence of serotonergic neurotransmission on pituitary hormone release in obese and non-obese females. Acta Endocrinol 1993;128:319-24.
54. Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD. Circadian, ultradian, and episodic release of beta-endorphin in men, and its temporal coupling with cortisol. J Clin Endocrinol Metab 1989;68:1019-26.
55. Iranmanesh A, Lizarralde G, Short D, Veldhuis JD. Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. J Clin Endocrinol Metab 1990;71:1276-83.
56. Schürmeyer TH. On the relationship between ACTH and cortisol secretion. Horm Metab Res 1987; Suppl. 16:6-8.
57. Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. 1990 Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nychthemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab 1990;71:452-63.
58. Schürmeyer TH, Brabant G, von zur Mühlen A. Evidence, that the hypothesis on a hypothalamic origin of Cushing's disease is not an outdated concept. In: Lüdecke DK, Chrousos GP, Tolis G, eds. ACTH, Cushing's Syndrome and other Hypercortisolemic States. New York: Raven Press 1990: 105-13.
59. Dammacco F, Puca FM, Rigillo N et al. Inhibitory effect of cyproheptadine administration on the sleep-related growth hormone secretion in man. Horm Metab Res 1977;9:224-45.
60. Hauser H, Schürmeyer TH, Brabant G, Rathke B, von zur Mühlen A. Effect of sleep and sleep deprivation on ACTH and cortisol secretion patterns. Acta Endocrinol (Kbh) 1989;120 (Suppl.1): 100-1.